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Abstract: We have recently discovered that the photodynamic action of many different 
photosensitizers (PSs) can be dramatically potentiated by addition of a solution containing a range 
of different inorganic salts. Most of these studies have centered around antimicrobial photodynamic 
inactivation that kills Gram-negative and Gram-positive bacteria in suspension. Addition of non-
toxic water-soluble salts during illumination can kill up to six additional logs of bacterial cells (one 
million-fold improvement). The PSs investigated range from those that undergo mainly Type I 
photochemical mechanisms (electron transfer to produce superoxide, hydrogen peroxide, and 
hydroxyl radicals), such as phenothiazinium dyes, fullerenes, and titanium dioxide, to those that 
are mainly Type II (energy transfer to produce singlet oxygen), such as porphyrins, and Rose Bengal. 
At one extreme of the salts is sodium azide, that quenches singlet oxygen but can produce azide 
radicals (presumed to be highly reactive) via electron transfer from photoexcited phenothiazinium 
dyes. Potassium iodide is oxidized to molecular iodine by both Type I and Type II PSs, but may also 
form reactive iodine species. Potassium bromide is oxidized to hypobromite, but only by titanium 
dioxide photocatalysis (Type I). Potassium thiocyanate appears to require a mixture of Type I and 
Type II photochemistry to first produce sulfite, that can then form the sulfur trioxide radical anion. 
Potassium selenocyanate can react with either Type I or Type II (or indeed with other oxidizing 
agents) to produce the semi-stable selenocyanogen (SCN)2. Finally, sodium nitrite may react with 
either Type I or Type II PSs to produce peroxynitrate (again, semi-stable) that can kill bacteria and 
nitrate tyrosine. Many of these salts (except azide) are non-toxic, and may be clinically applicable. 
Keywords: antimicrobial photodynamic inactivation; potentiation by inorganic salts; sodium azide; 
potassium iodide; potassium bromide; potassium thiocyanate; potassium selenocyanate; sodium 
nitrite 
 
1. Introduction 
The relentless rise in antibiotic resistance amongst pathogenic bacteria and fungi [1], has 
motivated a search for newer antimicrobial techniques, that will not only kill drug-resistant bacteria 
but, themselves, will not induce resistance to emerge [2]. One of these newer antimicrobial techniques 
is known as antimicrobial photodynamic inactivation (aPDI) [3,4]. aPDI is derived from a cancer 
therapy known as photodynamic therapy (PDY) that was discovered as long ago as 1900 [5]. 
Photodynamic therapy (PDT) relies on a non-toxic dye called a photosensitizer (PS), that can be 
excited by harmless visible light to a long-lived triplet state [6]. The triplet state can undergo one of 
two different photochemical reactions [7]. Firstly, the triplet PS can undergo an electron transfer 
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reaction between some surrounding electron donor or electron acceptor molecule, to form a radical 
anion or a radical cation. These radical species can further react with oxygen to form superoxide 
(O2−), hydrogen peroxide (H2O2), and hydroxyl radicals (HO), called the Type I photochemical 
pathway. Secondly, it can undergo energy transfer with ground state triplet oxygen to form excited 
state singlet oxygen (1O2) (see Figure 1). All these reactive oxygen species (ROS) can oxidize lipids, 
proteins, and nucleic acids, leading to cell damage and death.  
 
Figure 1. Jablonski diagram showing the photochemical mechanisms operating in antimicrobial 
photodynamic inactivation (aPDI). 
In order to use aPDI as an alternative approach to treat drug-resistant infections, it is necessary 
to ensure that the treatment is selective for pathogenic bacteria or fungal cells while, at the same time, 
sparing the normal host cells. This is generally accomplished by three methods [8]. Firstly, the PS 
molecules should be designed to selectively bind to, and be taken up by, the pathogenic 
microorganisms, and not by the host cells. This is generally done by ensuring the PS compounds 
possess a pronounced cationic charge, which not only ensures strong binding to the anionic residues 
on the microbial cells, but also ensures that the PS can penetrate through the outer membrane 
permeability barrier of Gram-negative bacteria. Secondly, the time between administration of the PS 
and shining the light (drug–light interval) should be short (few minutes) because the uptake by host 
cells is time-dependent, while the binding to bacteria is rapid [8]. Thirdly, the PS should be topically 
applied or injected into the infected area, and not given intravenously or orally, as would be done if 
PDT were being used to treat tumors. 
Many different types of PS structure have been tested for their ability to kill bacteria and fungi 
in vitro, whether growing as planktonic suspensions or as biofilms [9]. It should be pointed out that 
the requirement for a pronounced negative charge, mentioned above, only strictly applies to Gram-
negative bacteria, while anionic and neutral dyes can be highly active against Gram-positive bacteria. 
Figure 2 shows a selection of the PS chemical structures that will be discussed further in this review. 
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Figure 2. Chemical structures of several of the PS used in this paper. a, Triscationic fullerene BB6; b, 
conjugate between polyethylenimine and chlorin(e6) PEI-ce6; c, decacationic fullerene LC15; d, 
phenothiazinium methylene blue MB; e, hematoporphyrin derivative Photofrin PF; f, halogenated 
xanthene Rose Bengal RB; g, tetraanionic porphyrin TPPS4; h, tetracationic porphyrin TPMPy4; i, 
tetraanionic phthalocyanine ClAlPCS4. 
Despite the high interest being shown in antimicrobial PDT (aPDT) as a new approach to treat 
localized infections, it has not prevented a variety of laboratories from investigating ingenious ways 
to make it even better. Some of these approaches that have been reported can be summarized as 
combining aPDT with traditional antimicrobial compounds [10], improving the targeting capacity of 
PS by conjugating them to monoclonal antibodies that recognize bacteria [11] or to peptides that 
penetrate bacteria [12]; or combining PS with silver nanoparticles [13]. In the present review, we will 
discuss an entirely new approach to improving aPDI by combining the PS with simple non-toxic 
inorganic salts [14]. We will pay potential attention to attempting to explain the photochemical 
mechanisms and reactions involved in the oxidation of the inorganic ions. It should be pointed out 
that the concentration of inorganic salts that were used (10–400 mM) in these studies are not toxic to 
microbial cells after a 30 min incubation time. The original papers supplied this toxicity data. 
2. Azide 
We originally discovered the effect of inorganic salts on aPDI by working with sodium azide 
[15]. Sodium azide is frequently used as a classical physical quencher of singlet oxygen [16]. However, 
some workers have suggested that azide could also function as a chemical quencher of singlet 
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oxygen-producing azide radicals [17]. The idea, in aPDI, is that the addition of azide to a mixture of 
bacteria and PS will inhibit the killing to a greater or lesser extent, depending on how much Type II 
photochemistry (singlet oxygen) or Type I photochemistry (radicals) there is with that particular PS. 
We showed that this hypothesis was indeed correct by comparing two different PS: a tris-cationic-
buckminsterfullerene (BB6, Figure 2a), and a conjugate between polyethylenimine and chlorin(e6) 
(PEI-ce6, Figure 2b) [18]. PEI-ce6 mainly produced 1O2, since the killing was quenched by azide, while 
BB6 mainly produced Type I ROS, since the inhibition of bacterial killing was minimal. 
We next looked at whether sodium azide (10 mM) would inhibit aPDI mediated by the 
phenothiazinium dye, methylene blue (MB, Figure 2c) [15]. To our surprise, the bacterial killing was 
not inhibited at all but, instead, was paradoxically potentiated (Figure 3). Further investigation 
identified the formation of azide radicals by spin trapping and electron spin resonance spectrometry. 
Interestingly, the azide radical was still formed in the absence of oxygen, and significant bacterial 
killing was still obtained in the absence of oxygen when azide was added, but not without azide 
(Figure 4).  
The hypothesized mechanism is a simple photo-induced electron transfer between MB and 
azide, as shown in Equation (1). 
3PS + N3−  PS− + N3 (1) 
 
Figure 3. Paradoxical potentiation of methylene blue (MB) aPDI by addition of sodium azide. (A) S. 
aureus; (B) E. coli. Figure adapted from data contained in [15]. *** = p < 0.001. 
 
Figure 4. Oxygen-independent (under nitrogen) MB photoinactivation by addition of sodium azide. 
(A) S. aureus; (B) E. coli. Figure adapted from data contained in [15]. 
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We went on to compare six different homologous phenothiazinium dyes: MB, toluidine blue O 
(TBO), new methylene blue (NMB), dimethylmethylene blue (DMMB), azure A (AA), and azure B 
(AB)[19]. We found both significant potentiation (up to 2 logs) and, also, significant inhibition (>3 
logs) of killing by the addition of 10 mM azide, depending on Gram classification, washing the dye 
from the cells, and the precise dye structure (lipophilicity) as shown in Figure 5. Killing of Escherichia 
coli was potentiated with all 6 dyes after a wash, while Staphylococcus aureus killing was only 
potentiated by MB and TBO with a wash and DMMB with no wash. More lipophilic dyes with a 
higher log P value (octanol:water partition coefficient), such as DMMB, were more likely to show 
potentiation. We conclude that the Type I photochemical mechanism (potentiation with azide) likely 
depends on the microenvironment, i.e., higher binding of dye to bacteria. Bacterial dye-binding is 
thought to be higher with Gram-negative compared to Gram-positive bacteria, when unbound dye 
has been washed away, and with more lipophilic dyes. 
 
Figure 5. Comparison of six phenothizinium dyes for potentiation or inhibition of aPDI by sodium 
azide. Figure adapted from data contained in [19]. 
We studied three decacationic fullerene monoadducts LC14, LC15 (Figure 2d), and LC16, excited 
by white or UVA light (340–380 nm) [20]. Bacterial killing was not much inhibited by the addition of 
azide anions and, in some combinations, was potentiated. In the absence of oxygen, microbial 
photokilling was highly potentiated (up to 5 logs) by the addition of azide anions (see Figure 6). We 
concluded that molecular functionality, that encourages Type I electron transfer, increases the ability 
of photoactivated fullerenes to kill microbial cells. Oxygen-independent photokilling is possible with 
fullerene monoadducts in the presence of azide anions, probably mediated by azidyl radicals. UVA 
excitation may kill bacteria partly by an electron transfer mechanism directly into bacteria, as well as 
by ROS.  
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Figure 6. Oxygen-independent (under argon) LC15 fullerene photoinactivation by addition of sodium 
azide. (A) methicillin resistant S. aureus (MRSA); (B) E. coli. Figure adapted from data contained in 
[20]. 
3. Iodide 
Titanium dioxide (TiO2 known as titania) is a large band-gap semiconductor that is excited by 
UVA light [21]. When TiO2 nanoparticles with an average diameter of 25 nm (P25) [22] are mixed 
with bacteria, and excited by artificial UVA light or by natural sunlight, the bacteria are killed in a 
process known as antimicrobial photocatalysis [23]. These TiO2 NPs can produce ROS by two distinct 
mechanisms after photoexcitation. Absorption of a high-energy photon boosts electrons into the 
conductance band (Equation (2)). Firstly, these free electrons can transfer to oxygen to reduce it to 
superoxide radicals (Equation (3)). Secondly, the positive holes (h+) that are left in the TiO2 can oxidize 
water to produce hydroxyl radicals (Equation (4)). 
TiO2 + hv  h+ + e−(aq) (2) 
e−(aq) + O2  O2− (3) 
h+ + H2O  HO + H+ (4) 
We reported that the addition of potassium iodide solution (10 mM or 100 mM) to suspensions 
of P25 TiO2 that were illuminated with 360 nm light could drastically potentiate the microbial killing 
[24]. Up to 6 logs additional killing of Gram-positive bacteria, Gram-negative bacteria, and fungi was 
obtained (Figure 7). The microbial killing depended on the concentration of TiO2, the fluence of UVA 
light, and the concentration of potassium iodide (KI) (the best effect was at 100 mM). There was 
formation of long-lived antimicrobial species (probably hypoiodite and iodine) in the reaction 
mixture (detected by adding bacteria after light), but short-lived antibacterial reactive species 
(bacteria present during light) produced more killing. Tri-iodide (which has an absorption peak at 
350 nm and forms a blue product with starch) was produced by TiO2–UVA–KI, but was much 
reduced when MRSA cells were also present. The model tyrosine substrate, N-acetyl tyrosine ethyl 
ester, was iodinated in a light dose-dependent manner. 
 
Figure 7. Titanium dioxide photocatalysis is potentiated by potassium iodide. (A) MRSA; (B) E. coli; 
(C) C. albicans. Figure adapted from data contained in [24]. 
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We proposed that the mechanism involved oxidation of iodide anion by the holes produced 
during photocatalysis, in either a one-electron oxidation to form iodine radicals and then free iodine 
(Equation (5)), or in a two-electron oxidation to form iodonium cations and then hypoiodite (Equation 
(6)). 
h+ + I−  I ; 2I  I2 (5) 
2h+ + I−  I+ ; I+ + H2O  HOI + H+ (6) 
We then tested the phenothiazinium dye MB with KI [25]. Considering our finding with MB and 
azide [15], we initially supposed that Type I photochemistry would be required for the oxidation of 
iodide anion to bactericidal iodine species. Since we had used a concentration of 10 mM with sodium 
azide, we also used a concentration of 10 mM with potassium iodide [25] (see Figure 8). Although we 
achieved significant potentiation, the amount was not as high as was achieved later using higher KI 
concentrations. In this case, the mechanism appeared to be a combination of the production of stable 
antimicrobial species (free iodine and hypoiodite) and short-lived reactive species (iodine radicals). 
The concentration of KI turned out to be critical in determining the exact mechanism of microbial 
killing. If the concentration used is relatively low (up to 10 mM), then iodine radicals are mainly 
responsible but, if the KI concentration is increased up to 100 mM (or even higher up to 400 mM), 
then free iodine becomes mainly responsible.  
 
Figure 8. MB mediated aPDI is potentiated by potassium iodide. (A) S. aureus; (B) E. coli. Figure 
adapted from data contained in [25]. 
As mentioned above, we had previously believed that Type I photochemistry or, alternatively, 
photocatalysis, would be necessary to oxidize iodide to iodine. This assumption would change, 
however, when we investigated an anticancer PS called Photofrin (Figure 2e), which is a water-
soluble porphyrin derivative usually injected intravenously, that has been shown to be completely 
unable to kill any Gram-negative bacteria when excited by light [26]. When 100 mM KI solution was 
added to suspensions of microbial cells (108/mL) + PF (10 μM hematoporphyrin equivalent) + 415 nm 
light (10 J/cm2), we were able to eradicate (>6 log killing) five different Gram-negative species (E. coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus mirabilis, and Acinetobacter baumannii), whereas 
no significant killing at all was obtained without KI [27] (see Figure 9).  
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Figure 9. aPDI mediated by Photofrin kills Gram-negative bacteria in the presence of potassium 
iodide. Figure adapted from data contained in [27]. 
The mechanism of action appeared to be the generation of microbicidal molecular iodine (I2/I3−), 
as shown by comparable bacterial killing when cells were added to the mixture after completion of 
illumination, and light-dependent generation of free iodine, as detected by the formation of the starch 
complex. Gram-positive methicillin-resistant S. aureus is much more sensitive to aPDI (200–500 nM 
PF) and, in this case, potentiation by KI may be mediated mainly by short-lived iodine-reactive 
species. The fungal yeast Candida albicans displayed intermediate sensitivity to PF-mediated aPDI, 
and killing was also potentiated by KI. The reaction mechanism occurred via singlet oxygen (1O2). KI 
quenched 1O2 luminescence (1270 nm) at a rate constant of 9.2 × 105 M−1 s−1. Oxygen consumption was 
increased when PF was illuminated in the presence of KI. Hydrogen peroxide (but not superoxide) 
was generated from illuminated PF in the presence of KI. Sodium azide completely inhibited the 
killing of E. coli with PF/blue light + KI.  
The Equations for the reaction of singlet oxygen with iodide are shown below (Equations (7)–
(10)). 
1O2 + 3I− + 2H2O  I3− + 2H2O2 (7) 
Considering possible reactive intermediates in these reactions, an interesting paper by Dalmazio 
et al. [28] from Brazil used mass spectrometry and ab initio free energy calculations to study the 
decomposition of hydrogen peroxide in the presence of iodide anions. They detected a species with 
m/z = 287 that was proposed to be HOOI2− and explained its formation as depicted in Equations (5) 
and (10).  
I− + 2H2O2 + H+  IOOH + 2H2O (8) 
IOOH + I−  HOOI2− (9) 
The free energy calculations revealed that the most thermodynamically favored decomposition 
pathway of HOOI2− was via Equation (11), to give two radicals, I2− and HOO. 
HOOI2−  I2− + HOO (10) 
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We next tested another PS that has been shown to be effective in killing Gram-positive bacteria, 
but not Gram-negative species, namely, the halogenated xanthene dye, Rose Bengal (RB, Figure 2f) 
[29]. Similar to the results described above with Photofrin, we found that addition of 100 mM KI 
potentiated green light (540 nm) mediated killing by up to 6 extra logs, of a broad spectrum of 
microbial species, including E. coli, P. aeruginosa, S. aureus, and C. albicans. Again, the mechanism was 
proposed to be singlet oxygen addition to iodide anion to form peroxyiodide, as described above. We 
also showed that addition of KI could potentiate RB-mediated photodynamic therapy in a mouse 
model of skin abrasions infected with bioluminescent P. aeruginosa. The use of bioluminescent 
bacteria and low-light imaging allows the non-invasive monitoring of the infectious burden in real 
time. As can be seen from Figure 10, only the combination of RB, KI, and light produced a dose-
dependent loss of bioluminescence that was not seen with PDT alone (RB + light). 
 
Figure 10. PDT using Rose Bengal plus potassium iodide can eradicate P. aeruginosa in a mouse 
infection model. Figure reproduced from [29], open access. 
In an attempt to show the importance of PS–bacterial binding, we compared two differently 
charged porphyrins, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrin dihydrochloride (TPPS4, 
Figure 2g, thought to be anionic and, therefore, not able to bind to Gram-negative bacteria) and tetra-
(N-methyl-4-pyridyl)porphyrin (TMPyP4, Figure 2h, considered to be cationic and well able to bind 
to all bacteria) and produce some killing on its own, as well as eradication, when combined with KI 
(Figure 11A) [30]. As expected, TPPS4+light did not kill Gram-negative E. coli but, surprisingly when 
100 mM KI was added, TPPS4 was highly effective (eradication at 10 μM + 10 J/cm2 of 415 nm light) 
(Figure 11B). TPPS4 was more effective than TMPyP4 in eradicating MRSA and C. albicans (regardless 
of KI). TPPS4 was also highly active against E. coli after a centrifugation step when KI was added, 
suggesting that the supposedly anionic porphyrin did, in fact, bind to bacteria (both Gram-positive 
and Gram-negative) and to Candida. This was confirmed by uptake experiments. We next compared 
the phthalocyanine tetrasulfonate derivative (ClAlPCS4, Figure 2i), which did not bind to bacteria or 
allow KI-mediated killing of E. coli after a spin, suggesting it was, indeed, truly anionic; see Figure 
11C. We conclude that TPPS4 behaves as if it has some cationic character in the presence of bacteria, 
which may be related to its delivery from suppliers in the form of a dihydrochloride salt.  
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Figure 11. Potentiation of aPDI of E. coli with potassium iodide reveals that TPPS4 behaves like a 
cationic porphyrin. (A) TPMPy4; (B) TPPS4; (C) ClAlPCS4. Figure adapted from data contained in 
[30]. 
4. Bromide 
Because we had found that KI was so effective in potentiating aPDI, we wanted to test sodium 
bromide, a close analog of KI. However, when we tested several of the PSs that we had previously 
shown to undergo strong potentiation with KI addition (including PF, RB, MB, TPPS4, or TMPyP4), 
we were not able to detect any potentiation of killing of Gram-positive and Gram-negative bacteria, 
or fungi, by the addition of KBr. It was not until we tested the P25 TiO2 NPs (described in the previous 
section), for antimicrobial photocatalysis, that we found anything interesting [31]. When KBr (0–10 
mM) was added to photoactivated TiO2 (P25), it potentiated the killing of Gram-positive (MRSA), 
Gram-negative (E. coli) bacteria and fungi (C. albicans), by up to 3 logs, as shown in Figure 12. We 
found that the mechanism of potentiation was probably due to generation of both short- and long-
lived oxidized bromine species, including hypobromite, as shown by the following observations. 
There was some antimicrobial activity remaining in solution after switching off the light, that lasted 
for 30 min but not 2 h, and oxidized 3,3′,5,5′-tetramethylbenzidine. N-acetyl tyrosine ethyl ester was 
brominated in a light dose-dependent manner, however, no bromine or tribromide ion could be 
detected by spectrophotometry or LC-MS. The mechanism appears to have elements in common with 
the antimicrobial system (myeloperoxidase + hydrogen peroxide + bromide). Therefore, the 
mechanism can be clearly differentiated from the mechanisms applying to iodide, where it is quite 
clear that singlet oxygen is able to oxidize iodide to cytotoxic free iodine. Although hydroxyl radical 
has a redox potential (+2.31 V) that is more than enough to oxidize bromide (−0.78 V), singlet oxygen 
does not (+0.64 V) [32]. The minor inhibition of the TiO2-mediated photoactivation of singlet oxygen 
sensor green (SOSG) by bromide is probably caused by the physical quenching of 1O2, caused by its 
collision with bromide ions in a similar manner to that shown for iodide ions [33]. Therefore, we 
assumed that bromide oxidation was caused by a direct oxidation arising from the photoactivated 
TiO2, rather than oxidation by an intermediate oxygen-containing oxidizing species.  
 
Figure 12. Titanium dioxide photocatalysis is potentiated by potassium bromide. (A) MRSA; (B) E. 
coli; (C) C. albicans. Figure adapted from data contained in [31]. 
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When TiO2 is irradiated by UVA light, it acts as an oxidizing agent, due to the positive holes 
generated in the valence band by excitation of electrons into the valence band. Water can be oxidized 
to oxygen, showing that the oxidizing potential is at least +1.23 V. The redox potential of bromide to 
hypobromite is lower (−0.76 V) than the redox potential for bromide to bromine (−1.07 V), showing 
that bromide may be preferentially oxidized to hypobromite, rather than bromine. 
2 H2O(l)  O2(g) + 4H+(aq) + 4e−   Eoox = −1.23 V (11) 
H2O + Br−  2e− + 2H+ + BrO−    Eoox = −0.76V (12) 
2 Br−  2e− + Br2   Eoox = −1.07V (13) 
However, there is another difference. The oxidation to hypobromite is a true 2-electron 
oxidation, while the oxidation to bromine is two separate 1-electron oxidations that proceed via the 
short-lived intermediate bromine radical: 
Br−  Br + e−. (14) 
By contrast, the first step in the 2-electron oxidation to hypobromite is 
Br−  Br+ + 2e−. (15) 
Bromide initially reacts to form the bromonium cation, that subsequently reacts with water to 
form hypobromite: 
Br+ + H2O  HOBr + H+. (16) 
5. Thiocyanate 
Pseudohalides are polyatomic analogues XY(Z)− of halide anions that, in some cases, form 
dimeric molecules akin to halogens, called pseudohalogens. The chemistry of pseudohalogens 
resembles that of the true halogens, allowing them to substitute for halogens in several classes of 
chemical compounds [34]. We asked whether thiocyanate (SCN−) could potentiate the killing of S. 
aureus and E. coli [35]. Addition of KSCN (up to 10 mM) enhanced PDT killing (10 μM MB, 5 J/cm2 of 
660 nm light) in a concentration-dependent manner. In the case of S. aureus, killing was increased by 
2.5 log10 steps to a maximum of 4.2 log10 steps at 10 mM, and increased killing of E. coli by 3.6 log10 to 
a maximum of 5.0 log10 at 10 mM (see Figure 13). We determined that SCN− rapidly depleted O2 from 
an irradiated MB system, reacting exclusively with 1O2, without quenching the MB excited triplet 
state. SCN− reacted with 1O2, producing a sulfur trioxide radical anion (a sulfur-centered radical) that 
was demonstrated by EPR spin-trapping, by comparison with authentic spectra. We found that MB-
PDT, with SCN− present in solution, produced both sulfite and cyanide anions, and that addition of 
each of these salts separately enhanced MB-PDT killing of bacteria. We were unable to detect EPR 
signals of HO which, together with kinetic data, strongly suggests that MB, known to produce HO 
and 1O2, may, under the conditions used, preferentially form 1O2.  
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Figure 13. MB-mediated aPDI is potentiated by potassium thiocyanate. (A) S. aureus; (B) E. coli. Figure 
adapted from data contained in [35]. 
The proposed mechanism of production of sulfur trioxide radical anion can be seen in Equations 
(17)–(19), involving both an addition reaction of 1O2 (Type II), as well a one-electron transfer to sulfite 
(Type I). This unusual sequence of reactions explains why purely Type II PSs (such as PF, RB, TPPS4) 
are not potentiated by KSCN. Apparently only PSs that can carry out a mixture of Type I and Type II 
mechanisms can be potentiated by KSCN. To confirm this hypothesis, we tested two other 
phenothiazinium dyes, namely, new methylene blue and dimethylmethylene blue [36]. Both of these 
dyes produced additional aPDI killing in the presence of KSCN, but RB and TPPS4 did not (data not 
shown) [36]. 
SCN + 1O2  SO2CN− (17) 
SO2CN− + H2O  H2SO3 + CN− (18) 
H2SO3 + e−  SO3−• + 2H+ (19) 
6. Selenocyanate 
Due to the success we obtained in potentiating aPDI with KSCN [35], we next tested another 
different pseudohalide salt, KSeCN [37]. We found that KSeCN (concentrations up to 100 mM) could 
also potentiate (up to 6 logs of killing) aPDI (S. aureus and E coli) mediated by a number of different 
PSs: MB + red light, RB + green light, and TPPS4 + blue light. TPPS4 was effective at concentrations 
as low as 200 nM. When a mixture of selenocyanate with these PSs in solution was illuminated, and 
then bacteria were added after the light, there was up to 6 logs of killing (Gram-negative > Gram-
positive) but the antibacterial species that was formed decayed rapidly (all gone by 20 min) (see 
Figure 14). Our hypothesis to explain this antibacterial activity was the formation of selenocyanogen 
(SeCN)2 by reaction of KSeCN with singlet oxygen (1O2), as shown by quenching of 1O2 by SeCN and 
increased photoconsumption of oxygen. The fact that lead tetraacetate reacted with SeCN (this is a 
literature preparation of (SeCN)2 [38,39]), to produce a short-lived antibacterial species, supported 
this hypothesis.  
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Figure 14. aPDI mediated by TPPS4 + potassium selenocyanate in “after” format. (A) Killing of MRSA 
and E. coli as a function of TPPS4 concentration; (B) Time-dependent decay of antibacterial activity of 
TPPS4 + KSeCN + light. Figure adapted from data contained in [37]. 
The proposed reaction is as follows: 
2KSeCN + 1O2 + 2H+  (SeCN)2 + H2O2. (20) 
We were intrigued by the obvious difference in reaction mechanisms when thiocyanate and 
selenocyanate were compared as potentiating salts for aPDI. We, therefore, compared these two salts 
with light-activated PSs, and with other different oxidative reactions for killing Gram-positive and 
Gram-negative bacteria [36]. Overall, KSeCN was more powerful than KSCN, and worked with a 
wider range of PSs, while (as mentioned above) KSCN only worked with phenothiazinium salts. 
KSeCN produced killing when cells were added after light, suggesting production of a semi-stable 
species (SeCN)2, while KSCN did not. We tested three different oxidative reactions that each have the 
potential ability to kill bacteria: (a) lead tetraacetate; (b) Fenton reagent (hydrogen peroxide and 
ferrous sulfate); (c) hydrogen peroxide and horseradish peroxidase (H2O2/HRP). In every case, 
KSeCN was substantially more effective (several logs) than KSCN in potentiating the bacterial killing 
(see Figure 15). We concluded that (SeCN)2 is a mediator for aPDT using KSeCN, whereas sulfur 
trioxide radical anion is the mediator for aPDT using phenothiazinium salts potentiated by KSCN. 
For H2O2/HRP with KSCN, hypothiocyanite (OSCN−) has been proposed to function as the 
antibacterial agent in the literature [40–42], while hyposelenocyanite is said “not to exist” [43]. Lead 
tetraacetate is known to produce (SeCN)2 from KSeCN, as well as the analogous (SCN)2 from KSCN 
[44,45]. The mediators from Fenton reaction are unclear (pseudohalogen radical ions?). Both KSCN 
(which occurs naturally in the human body [46]) and KSeCN (that has been proposed as a dietary 
selenium supplement [47]) may be clinically applicable. 
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Figure 15. Comparison of thiocyanate and selenocyanate for potentiation of four different oxidative 
techniques against E. coli. (A) aPDI with TPPS4; (B) lead tetraacetate; (C) horseradish peroxidase and 
hydrogen peroxide; (D) Fenton reagent (Fe2+ + H2O2). Figure adapted from data contained in [36]. 
7. Nitrite 
Although this data is, as yet, unpublished, we will briefly discuss potentiation of aPDI by the 
addition of sodium nitrite. It has been shown by Laura Pecci in Rome, Italy, that the photoactivation 
of some PS in the presence of nitrite can lead to nitration of tyrosine. One paper [48] used MB 
activated by red light, and another paper [49] used riboflavin activated by UVA light. In both cases, 
the mechanism of action was attributed to a Type 1 process that initially led to the simultaneous 
production of a tyrosine radical and a nitrogen dioxide radical, and that these two radicals then 
recombined to produce nitrotyrosine.  
We next tested whether the addition of sodium nitrite could potentiate aPDI killing of MRSA 
and E. coli bacteria (submitted for publication). Addition of up to 100 mM nitrite gave 6 logs of extra 
killing of E. coli in the case of Rose Bengal excited by green light, and 2 logs of extra killing in the case 
of MRSA using RB + green light. Comparable results were obtained for other PS (TPPS4 excited by 
blue light and MB excited by red light); see Figure 16. These findings suggest that nitrite reacts with 
PDT-produced ROS to produce a stronger oxidizing agent than singlet oxygen alone, and we 
hypothesized that peroxynitrate may be a candidate for this strong oxidizing agent. Some bacterial 
killing was obtained after light using a fullerene (LC15) + nitrite, and tyrosine ester amide was 
nitrated both “in” and “after” modes with all four PS.  
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Figure 16. aPDI is potentiated by sodium nitrite. (A) MRSA; (B) E. coli. Unpublished data submitted 
for publication. 
Peroxynitrate could be formed by a reaction between superoxide and nitrogen dioxide; 
formation of the latter was demonstrated by spin trapping with nitromethane.  
8. Conclusions 
It has taken us considerable time to figure out the mechanistic complexities of the phenomenon 
of potentiation of aPDI by addition of various inorganic salts. Partly, this confusion was due to an 
initial assumption that Type I photochemistry was dominant in this effect. Since we had clearly 
established that Type I electron transfer was the mechanism responsible for potentiation with azide 
(necessarily so, because azide inhibits Type II energy transfer to singlet oxygen), we assumed this 
argument would also apply to other salts and, hence, we first tested TiO2 photocatalysis with iodide. 
This was successful, so we then tested iodide with MB, a dye well known to undergo Type I 
photochemistry, as shown by potentiation with azide [15]. This experiment again was successful, 
although perhaps the potentiation was not as strong as we first anticipated, using only 10 mM iodide 
[25]. We were quite surprised when we tested Photofrin with iodide, as we did not expect singlet 
oxygen to efficiently oxidize iodide [27]. However, by then, we had realized that we needed to use 
relatively high concentrations of KI (i.e., 100 mM instead of only 10 mM). The excellent potentiation 
observed with PF and iodide encouraged us to next test RB with iodide, and this combination was 
equally successful [29]. The experiments with the two porphyrins (TMPyP4 and TPPS4), although 
they uncovered interesting data on the actual charge borne on the tetrapyrroles, served to confirm 
the ability of 1O2 to oxidize iodide to produce antimicrobial species [30]. 
None of the other PSs we tested were able to oxidize bromide, therefore, only antimicrobial 
photocatalysis using TiO2 was able to be potentiated by bromide [31]. Moreover, the mechanisms of 
oxidation of halide anions appeared to be different between iodide and bromide, as well as between 
different PSs. In the case of photocatalysis, we detected formation of only hypobromite from bromide 
(no free bromine), and a mixture of free iodine and hypoiodite with iodide. By contrast, with other 
PSs (singlet oxygen-producing) there was no oxidation of bromide, and only free iodine was formed 
with iodide [24].  
In the case of photoinduced electron transfer mechanisms with azide, it was possible to obtain 
oxygen-independent microbial killing, which could be explained by formation of cytotoxic azidyl 
radicals [15]. The fact that oxygen-independent bacterial killing was also observed with fullerenes 
(which are well known to undergo photoinduced electron transfer), confirmed this hypothesis [20].  
Another interesting and initially confusing comparison was that between thiocyanate and 
selenocyanate. When it was found that only aPDI mediated by phenothiazinium dyes could be 
potentiated by thiocyanate, while PSs that are more likely to operate via a Type II mechanism were 
unaffected, this observation pointed us toward the dual role of Type II, followed by Type I, in 
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producing a bactericidal species (sulfur trioxide radical anion) from thiocyanate. However, with 
selenocyanate, the story was different, and the action of singlet oxygen led to the formation of a semi-
stable species that could only be provisionally identified as selenocyanogen, and which was 
supported by the formation of a similar acting semi-stable antimicrobial species formed from the 
reaction between KSeCN and Pb(OAc)4. However, KSCN did indeed appear to produce a semi-stable 
antibacterial species when reacted with Pb(OAc)4, although it was not as powerful as an antimicrobial 
agent as that formed from KSeCN and Pb(OAc)4. We confirmed that peroxidase/hydrogen peroxide 
was able to produce an antimicrobial species from KSCN, which has been widely attributed in the 
literature to be hypothiocyanite [40–42], but we also found that KSeCN could produce microbial 
killing from HRP/H2O2. It has been stated in the literature that “hyposelenocyanite does not exist”, 
although how it is possible to prove the non-existence of a compound is not entirely clear [43].  
Yet another interesting mechanistic puzzle was provided by the case of nitrite. The data from 
Pecci et al. suggested that the tyrosine nitration reaction observed when nitrite was added to 
photoactivated MB [48] and RF [49], in the presence of tyrosine, depended on Type I photochemistry. 
However, the fact that killing was observed after light (at least in the case of photoactivated 
fullerenes) suggested that a semi-stable antimicrobial species was produced, in contrast to the radical 
species suggested by Pecci.  
Taken together, the teasing apart of the different reaction mechanisms, involved in the 
potentiation of aPDI by inorganic salts, has been a fascinating challenge. Not only has this research 
uncovered some novel reaction pathways, but it may also be of clinical relevance. Many of these salts 
occur naturally in the human body (nitrite and thiocyanate) or, else, possess low toxicity (iodide and 
selenocyanate). The fact that addition of iodide has been shown to be beneficial in multiple mouse 
models of localized infections is also highly encouraging. 
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